Format

Send to

Choose Destination
See comment in PubMed Commons below
Br J Dermatol. 2013 Dec;169(6):1342-5. doi: 10.1111/bjd.12458.

Molecular evidence of type 2 mosaicism in Gorlin syndrome.

Author information

1
Department of Dermatology , Hospital del Niño Jesús, Menendez Pelayo 65, Madrid, 28034, Spain.

Abstract

We present a 12-year-old girl with a family history of Gorlin syndrome who had unilateral, segmentally arranged basaloid skin tumours present since birth, ipsilateral, palmoplantar pits of rather large size distributed along Blaschko lines, and an ipsilateral odontogenic keratocyst. The patient and her father were heterozygous for a germline mutation in the form of a single-base substitution in exon 18 of the PTCH1 gene. In the patient's lesional skin, a microdeletion in exon 3 of PTCH1 was detected, giving rise to a truncated protein. This additional mutation was ruled out in the contralateral skin and in blood lymphocytes, thus confirming its mosaic state. In this way we provide for the first time molecular proof of a type 2 segmental involvement of this autosomal dominant trait.

PMID:
23746055
DOI:
10.1111/bjd.12458
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center